These Numbers Could Change Investor Views For Erasca Inc (NASDAQ: ERAS)
Currently, there are 259.85M common shares owned by the public and among those 166.48M shares have been available to trade. The company’s stock has a 5-day price change of 12.96% and 12.96% over the past three months. ERAS shares are trading 14.55% year to date (YTD), with the 12-month market performance down to -8.61% lower. […]
There Is Clear Momentum For Erasca Inc (NASDAQ: ERAS)
Erasca Inc (ERAS) concluded trading on Wednesday at a closing price of $2.20, with 3.26 million shares of worth about $7.18 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 4.27% during that period and on June 26, 2024 the price saw a gain […]
Now Is A Suitable Moment For A Long-Term Purchase Of Erasca Inc (NASDAQ: ERAS)
Armistice Capital LLC recently announced the acquisition of new stake in Erasca Inc (NASDAQ:ERAS). The institutional investor has increased its shareholding in the Healthcare company by 6.36% to 8.36 million shares with purchase of 0.5 million shares. This fresh investment now brings its stake to 5.53% valued currently at $17.8 million. In addition, BlackRock Fund […]
Erasca Inc (ERAS): Insights At A Glance
Armistice Capital LLC has recently announced that it has increased stake in Erasca Inc (NASDAQ:ERAS) by 6.36%. After grabbing 8.36 million shares, the institutional investor is now in possession of 0.5 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 5.53% having worth around $19.3 million. Moreover, BlackRock […]
